
Background: Overlapping cerebrospinal fluid biomarkers (CSF) levels between Alzheimer’s disease (AD) and non-AD patients decrease differential diagnostic accuracy of the AD core CSF biomarkers. Amyloid-β (Aβ) isoforms might improve the AD versus non-AD differential diagnosis. Objective: To determine the added diagnostic value of Aβ isoforms, Aβ1-37, Aβ1-38, and Aβ1-40, as compared to the AD CSF biomarkers Aβ1-42, T-tau, and P-tau181P. Methods: CSF from patients with dementia due to AD (n = 50), non-AD dementias (n = 50), mild cognitive impairment due to AD (n = 50) and non-demented controls (n = 50) was analyzed with a prototype multiplex assay using MSD detection technology. The non-AD group consisted of frontotemporal dementia (FTD; n = 17), dementia with Lewy bodies (DLB; n = 17), and vascular dementia (n = 16). Results: Aβ1-37 and Aβ1-38 increased accuracy to differentiate AD from FTD or DLB. Aβ1-37, Aβ1-38, and Aβ1-40 levels correlated with Mini-Mental State Examination scores and disease duration in dementia due to AD. The Aβ1-42/Aβ1-40 ratio improved diagnostic performance of Aβ1-42 in most differential diagnostic situations. Aβ1-42 levels were lower in APOE ε4 carriers compared to non-carriers. Conclusions: Aβ isoforms help to differentiate AD from FTD and DLB. Aβ isoforms increase diagnostic performance of Aβ1-42. In contrast to Aβ1-42, Aβ isoforms seem to be correlated with disease severity in AD. Adding the Aβ isoforms to the current biomarker panel could enhance diagnostic accuracy.
NATIONAL INSTITUTE, Male, MILD COGNITIVE IMPAIRMENT, differential, diagnosis, BIOMARKERS, tau Proteins, GUIDELINES, cerebrospinal fluid, DISEASE, RECOMMENDATIONS, Statistics, Nonparametric, Alzheimer Disease/cerebrospinal fluid, Diagnosis, Differential, mild cognitive impairment, Apolipoproteins E, Alzheimer Disease, Humans, Protein Isoforms, Aged, Aged, 80 and over, Protein Isoforms/cerebrospinal fluid, INTERNATIONAL WORKSHOP, Amyloid beta-Peptides, tau Proteins/cerebrospinal fluid, amyloid, Alzheimer's disease, ALZHEIMERS ASSOCIATION WORKGROUPS, Middle Aged, LEWY BODIES, Amyloid beta-Peptides/cerebrospinal fluid, ROC Curve, Dementia/cerebrospinal fluid, Dementia, Female, aged, 80 and over, CONSENSUS, Mental Status Schedule, Apolipoproteins E/genetics, biological markers
NATIONAL INSTITUTE, Male, MILD COGNITIVE IMPAIRMENT, differential, diagnosis, BIOMARKERS, tau Proteins, GUIDELINES, cerebrospinal fluid, DISEASE, RECOMMENDATIONS, Statistics, Nonparametric, Alzheimer Disease/cerebrospinal fluid, Diagnosis, Differential, mild cognitive impairment, Apolipoproteins E, Alzheimer Disease, Humans, Protein Isoforms, Aged, Aged, 80 and over, Protein Isoforms/cerebrospinal fluid, INTERNATIONAL WORKSHOP, Amyloid beta-Peptides, tau Proteins/cerebrospinal fluid, amyloid, Alzheimer's disease, ALZHEIMERS ASSOCIATION WORKGROUPS, Middle Aged, LEWY BODIES, Amyloid beta-Peptides/cerebrospinal fluid, ROC Curve, Dementia/cerebrospinal fluid, Dementia, Female, aged, 80 and over, CONSENSUS, Mental Status Schedule, Apolipoproteins E/genetics, biological markers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 86 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
